The Food and Drug Administration has accepted the first regulatory approval application for a generic version of a cancer drug made by Eisai.
Walgreens on Tuesday named Jeffrey Kang and Mike Ellis to its pharmacy, health and wellness division.
Business Leader Magazine has given its 2011 Movers & Shakers Award to Nancy McFarlane, president of specialty pharmacy provider MedPro Rx, the company said.
Giant Food Stores is marking National Breast Cancer Awareness Month by donating more than $25,000 to organizations that address the disease, the Royal Ahold-owned supermarket chain said.
A growing number of people with Medicare are using free preventive services provided by the Affordable Care Act, the Centers for Medicare and Medicaid Services said.
German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.
Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.
A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.
Genomics has the potential to revolutionize the treatment of cancer and the drug industry, and the New York Pharma Forum is sponsoring a symposium on the subject in December.
The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.